Last reviewed · How we verify
Intravitreal Adalimumab
At a glance
| Generic name | Intravitreal Adalimumab |
|---|---|
| Sponsor | Centro de Pesquisa Rubens Siqueira |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases (PHASE1, PHASE2)
- Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis (PHASE2)
- Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS (NA)
- Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (PHASE2)
- Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |